Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTSS-IA: Argatroban + rt-PA + IA in Ischemic Stroke
NCT02448069Phase 2Completed
- Sponsor
- UTHealth Houston
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of argatroban in ischemic stroke, sponsored by UTHealth Houston. Started May 2015; status: completed.
02
Drugs
argatroban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02448069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448069.